Stock Events

Hercules Capital 

$21.22
2445
+$0.04+0.19% Friday 20:00

Statistik

Dagens högsta
21.38
Dagens lägsta
21.17
52V högsta
21.38
52V lägsta
14.09
Volym
1,005,708
Genomsnittlig volym
743,284
Marknadsvärde
3.44B
P/E förhållande
9.65
Utdelningsavkastning
7.54%
Utdelning
1.6

Kommande

Utdelningar

7.54%Utdelningsavkastning
10-års tillväxt
2.58%
5 års tillväxt
4.73%
3 års tillväxt
7.44%
1 års tillväxt
1.27%

Inkomster

2MayBekräftad
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.36
0.43
0.49
0.56
Förväntad EPS
0.5
Verklig EPS
0.5

Människor följer också

Den här listan baseras på bevakningslistorna för människor på Stock Events som följer HTGC. Det är inte en investeringsrekommendation.

Konkurrenter

Denna lista är en analys baserad på nyliga marknadshändelser. Det är inte en investeringsrekommendation.
Ares Capital
ARCC
Marknadsvärde12.81B
Ares Capital Corporation är en ledande konkurrent inom företagsutvecklingsföretag (BDC) och erbjuder liknande finansiella tjänster och investeringar i medelstora företag.
Golub Capital BDC
GBDC
Marknadsvärde2.69B
Golub Capital BDC, Inc. erbjuder finansieringslösningar till företag inom mellanmarknaden och konkurrerar direkt med Hercules Capital inom samma sektor.
Prospect Capital
PSEC
Marknadsvärde2.31B
Prospect Capital Corporation fungerar som en BDC och investerar i privata och mikrokapitaliserade publika företag, vilket gör det till en direkt konkurrent till Hercules Capital.
Main Street Capital
MAIN
Marknadsvärde4.33B
Main Street Capital Corporation är ett ledande investeringsföretag som fokuserar på liknande investeringsstrategier som Hercules Capital och riktar sig till företag i den nedre mellanmarknaden.
TriplePoint Venture Growth BDC
TPVG
Marknadsvärde303.9M
TriplePoint Venture Growth BDC Corp. är specialiserat på investeringar i tillväxtfasen för företag och konkurrerar nära med Hercules Capitals fokus på innovativa och teknikdrivna företag.
FS KKR Capital
FSK
Marknadsvärde5.53B
FS KKR Capital Corp. är en BDC som konkurrerar med Hercules Capital genom att erbjuda skräddarsydda kreditlösningar till privata medelstora amerikanska företag.
Oaktree Specialty Lending
OCSL
Marknadsvärde1.53B
Oaktree Specialty Lending Corporation är en konkurrent på BDC-marknaden och fokuserar på att erbjuda flexibla finansieringslösningar till medelstora företag.
BlackRock TCP Capital
TCPC
Marknadsvärde924.38M
BlackRock TCP Capital Corp. är en direkt konkurrent som tillhandahåller skuldfinansiering och eget kapital till medelstora företag, på ett liknande sätt som Hercules Capitals investeringsstrategi.
New Mountain Finance
NMFC
Marknadsvärde1.32B
New Mountain Finance Corporation konkurrerar inom BDC-sektorn genom att fokusera på skuldebrev och lån till medelstora företag, liknande Hercules Capitals strategi.
Sixth Street Specialty Lending
TSLX
Marknadsvärde1.98B
TPG Specialty Lending, Inc. erbjuder direkta lån och finansieringslösningar till medelstora företag och konkurrerar i samma nisch som Hercules Capital.

Analytikerbetyg

19.6$Genomsnittligt pris mål
Den högsta uppskattningen är $21.5.
Från 5 betyg inom de senaste 6 månaderna. Detta är inte en investeringsrekommendation.
Köp
40%
Behåll
60%
Sälj
0%

Om

Finance
Investment Managers
Finance and Insurance
Securities and Commodity Exchanges
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.
Show more...
VD
Scott Bluestein
Anställda
100
Land
US
ISIN
US4270965084
WKN
000A0ERTZ

Noteringar